Literature DB >> 26759467

Improving Price Transparency in Cancer Care.

Nora B Henrikson1, Veena Shankaran2.   

Abstract

Mesh：

Year:  2016        PMID： 26759467     DOI： 10.1200/JOP.2015.006171

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  10 in total

1.  Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.

Authors:  Ya-Chen Tina Shih; Ying Xu; Lei Liu; Fabrice Smieliauskas
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

2.  Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.

Authors:  Grace L Smith; Patricia A Ganz; Justin E Bekelman; Steven J Chmura; James J Dignam; Jason A Efstathiou; Reshma Jagsi; Peter A Johnstone; Michael L Steinberg; Stephen B Williams; James B Yu; Anthony L Zietman; Ralph R Weichselbaum; Ya-Chen Tina Shih
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-08       Impact factor: 7.038

Review 3.  Financial Burden of Drugs Prescribed for Cancer-Associated Symptoms.

Authors:  Arjun Gupta; Leonce Nshuti; Udhayvir S Grewal; Ramy Sedhom; Devon K Check; Helen M Parsons; Anne H Blaes; Beth A Virnig; Maryam B Lustberg; Ishwaria M Subbiah; Ryan D Nipp; Sydney M Dy; Stacie B Dusetzina
Journal:  JCO Oncol Pract       Date:  2021-09-24

4.  Minimal access to male fertility prices online: an analysis of the Society for Assisted Reproductive Technology (SART) clinics.

Authors:  Ryan G Larsen; Cole S Bowdino; Melissa A Mathes; Stephanie L Gustin; Christopher M Deibert
Journal:  Transl Androl Urol       Date:  2020-10

5.  Using Shared Decision-Making Tools and Patient-Clinician Conversations About Costs.

Authors:  Nataly R Espinoza Suarez; Christina M LaVecchia; Oscar J Ponce; Karen M Fischer; Patrick M Wilson; Celia C Kamath; Annie LeBlanc; Victor M Montori; Juan P Brito
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-08-05

6.  The Cancer Financial Experience (CAFÉ) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship.

Authors:  Nora B Henrikson; Melissa L Anderson; John Dickerson; John J Ewing; Robin Garcia; Erin Keast; Deborah A King; Cara Lewis; Blake Locher; Carmit McMullen; Consuelo M Norris; Amanda F Petrik; Arvind Ramaprasan; Jennifer S Rivelli; Jennifer L Schneider; Lisa Shulman; Leah Tuzzio; Matthew P Banegas
Journal:  Trials       Date:  2022-05-13       Impact factor: 2.728

7.  Addressing Patients' Priorities as a Strategy to Improve Value.

Authors:  Yu-Ning Wong; Nancy Roach; Neal J Meropol
Journal:  Oncologist       Date:  2016-10-14

8.  The impact of PD-L1 on survival and value of the immune check point inhibitors in non-small-cell lung cancer; proposal, policies and perspective.

Authors:  Helmy M Guirgis
Journal:  J Immunother Cancer       Date:  2018-02-20       Impact factor: 13.751

9.  Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation Therapy.

Authors:  Rahul N Prasad; Vedat O Yildiz; Tejash Patel; Trevor J Royce; Joshua D Palmer
Journal:  Adv Radiat Oncol       Date:  2021-10-26

10.  Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain-a model-based analysis.

Authors:  Jan Norum; Margareth Aarag Antonsen; Terje Tollåli; Khalid Al-Shibli; Gry Andersen; Kristin Helene Svanqvist; Nina Helbekkmo
Journal:  ESMO Open       Date:  2017-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.